Related references
Note: Only part of the references are listed.B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial
Richard A. Furie et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis
David Jayne et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis
Brad H. Rovin et al.
KIDNEY INTERNATIONAL (2022)
COPA syndrome, 5 years after: Where are we?
Marie-Louise Fremond et al.
JOINT BONE SPINE (2021)
Improving medication adherence in patients with lupus nephritis
Nathalie Costedoat-Chalumeau et al.
KIDNEY INTERNATIONAL (2021)
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Brad H. Rovin et al.
LANCET (2021)
Low-Dose Interleukin-2 as an Alternative Therapy for Refractory Lupus Nephritis
Xia Zhang et al.
RHEUMATOLOGY AND THERAPY (2021)
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
Dimitrios Mougiakakos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Treatment of Systemic Lupus Erythematosus using BCMA-CD19 Compound CAR
Wenli Zhang et al.
STEM CELL REVIEWS AND REPORTS (2021)
An Update for Mesenchymal Stem Cell Therapy in Lupus Nephritis
Wenchao Li et al.
KIDNEY DISEASES (2021)
Effect of a Single Apolipoprotein L1 Gene Nephropathy Variant on the Risk of Advanced Lupus Nephritis in Brazilians
Gisele Vajgel et al.
JOURNAL OF RHEUMATOLOGY (2020)
Efficacy and safety of bortezomib in refractory lupus nephritis: a single-center experience
A. Segarra et al.
LUPUS (2020)
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
Eric F. Morand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Update on Lupus Nephritis: Core Curriculum 2020
Samir Parikh et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2020)
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Bortezomib-induced motor neuropathy: A case report
Meghana Singh et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2020)
Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus
Lennard Ostendorf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
Richard Furie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cyclophosphamide Versus Mycophenolate Versus Rituximab in Lupus Nephritis Remission Induction A Historical Head-to-Head Comparative Study
Rudra Prosad Goswami et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2019)
Treatment Options for Refractory Lupus Nephritis
Hans-Joachim Anders et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Autologous Hematopoietic Stem Cell Transplantation for Refractory Lupus Nephritis
Xianghua Huang et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes
Meggan Mackay et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Azathioprine and Mycophenolate Mofetil Adherence Patterns and Predictors Among Medicaid Beneficiaries With Systemic Lupus Erythematosus
Candace H. Feldman et al.
ARTHRITIS CARE & RESEARCH (2019)
Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1) a randomised, controlled, phase 3 trial
Richard A. Furie et al.
LANCET RHEUMATOLOGY (2019)
Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis
C-B Choi et al.
LUPUS (2018)
Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus
S. Iwata et al.
LUPUS (2018)
Multitarget therapy of mycophenolate mofetil and cyclosporine A for induction treatment of refractory lupus nephritis
D. Jesus et al.
LUPUS (2018)
APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD
Barry Freedman et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2018)
Outcomes of rituximab therapy in refractory lupus: A meta-analysis
Fatma Alshaiki et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY (2018)
Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia
Sara Barmettler et al.
JAMA NETWORK OPEN (2018)
Histologic versus clinical remission in proliferative lupus nephritis
Ana Malvar et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
The short-term efficacy of bortezomib combined with glucocorticoids for the treatment of refractory lupus nephritis
H. Zhang et al.
LUPUS (2017)
The value of repeat biopsy in lupus nephritis flares
Javier Narvaez et al.
MEDICINE (2017)
T cells and autoimmune kidney disease
Abel Suarez-Fueyo et al.
NATURE REVIEWS NEPHROLOGY (2017)
A randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritis
DanQi Deng et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Analysis of the effectiveness and safety of rituximab in patients with refractory lupus nephritis: a chart review
Anne Contis et al.
CLINICAL RHEUMATOLOGY (2016)
Molecular imaging of the kidney in lupus nephritis to characterize response to treatment
Samir V. Parikh et al.
Translational Research (2016)
Hydroxychloroquine Blood Levels in Systemic Lupus Erythematosus: Clarifying Dosing Controversies and Improving Adherence
Laura Durcan et al.
JOURNAL OF RHEUMATOLOGY (2015)
Therapeutic Drug Monitoring of Mycophenolic Acid in Lupus Nephritis: A Review of Current Literature
Paulina Luszczynska et al.
THERAPEUTIC DRUG MONITORING (2015)
Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases
K. D. Rainsford et al.
INFLAMMOPHARMACOLOGY (2015)
The multifaceted aspects of refractory lupus nephritis
Gabriella Moroni et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2015)
The Efficacy and Safety of Leflunomide for the Treatment of Lupus Nephritis in Chinese Patients: Systematic Review and Meta-Analysis
Heng Cao et al.
PLOS ONE (2015)
The value of repeat kidney biopsy in quiescent Argentinian lupus nephritis patients
A. S. Alvarado et al.
LUPUS (2014)
End-Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1
Barry I. Freedman et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Lupus Nephritis and End-stage Kidney Disease
Natallia Maroz et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2013)
Lupus Nephritis: Treatment of Resistant Disease
Sean Kalloo et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
New approaches for the treatment of lupus nephritis in the 21st century: from the laboratory to the clinic
Elia Ripoll et al.
IMMUNOTHERAPY (2013)
Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis
R. J. Davies et al.
LUPUS (2013)
Beyond the LUNAR trial. Efficacy of rituximab in refractory lupus nephritis
Marc Weidenbusch et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
The value of repeat biopsy in the management of lupus nephritis: an international multicentre study in a large cohort of patients
Fabio Pagni et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Long-term follow-up in lupus nephritis patients treated with rituximab-clinical and histopathological response
Thorunn Jonsdottir et al.
RHEUMATOLOGY (2013)
B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies
Maria J. Leandro
ARTHRITIS RESEARCH & THERAPY (2013)
Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells
H. Travis Ichikawa et al.
ARTHRITIS AND RHEUMATISM (2012)
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study
Philippe Moreau et al.
LANCET ONCOLOGY (2011)
The dual role of complement in the progression of renal disease in NZB/W F1 mice and alternative pathway inhibition
Hideharu Sekine et al.
MOLECULAR IMMUNOLOGY (2011)
Long-lived autoreactive plasma cells drive persistent autoimmune inflammation
Falk Hiepe et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Identification of Biomarkers That Predict Response to Treatment of Lupus Nephritis With Mycophenolate Mofetil or Pulse Cyclophosphamide
Maria Dall'Era et al.
ARTHRITIS CARE & RESEARCH (2011)
Long-term outcomes-mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases
Josefina Cortes-Hernandez et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system
Tobias Alexander et al.
BLOOD (2009)
Rituximab in Severe Lupus Nephritis: Early B-Cell Depletion Affects Long-Term Renal Outcome
Catherine Melander et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis
Iva Gunnarsson et al.
ARTHRITIS AND RHEUMATISM (2007)
Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus
RK Burt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial -: Lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial
FA Houssiau et al.
ARTHRITIS AND RHEUMATISM (2004)
Autologous stem cell transplantation for systemic lupus erythematosus
D Jayne et al.
LUPUS (2004)
Intravenous immunoglobulin g in the treatment of patients with chronic glomerulonephritis: Clinical experience lasting 15 years
D Monova et al.
NEPHRON (2002)
Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor
A Samuelsson et al.
SCIENCE (2001)
Intravenous immunoglobulin treatment of lupus nephritis
Y Levy et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2000)
Share Paper
